Oragenics, Inc. (OGEN) Appoints Al Fosmoe As Senior Vice President Of Operations/Product Development
4/22/2014 6:56:59 AM
Oragenics, Inc. (NYSE:MKT - OGEN), a leader in the development of novel, effective antibiotics and oral care probiotics, today announced that Mr. Al Fosmoe has joined Oragenics as Senior Vice President Operations/Product Development. The appointment is directly related to the progress Oragenics has made in the development of a new pipeline of novel antibiotics from its lantibiotic platform, and marks the expansion of the team dedicated to accelerating the progress of the lantibiotic pipeline.
Help employers find you! Check out all the jobs and post your resume.
comments powered by